EKGCX
Price
$20.98
Change
-$0.18 (-0.85%)
Updated
Jul 28 closing price
Net Assets
121.81M
RSLFX
Price
$77.19
Change
-$0.48 (-0.62%)
Updated
Jul 28 closing price
Net Assets
79.78B
Interact to see
Advertisement

EKGCX vs RSLFX

Header iconEKGCX vs RSLFX Comparison
Open Charts EKGCX vs RSLFXBanner chart's image
Allspring Special Global Small Cap C
Price$20.98
Change-$0.18 (-0.85%)
VolumeN/A
Net Assets121.81M
American Funds SMALLCAP World R5
Price$77.19
Change-$0.48 (-0.62%)
VolumeN/A
Net Assets79.78B
EKGCX vs RSLFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EKGCX vs. RSLFX commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKGCX is a Hold and RSLFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLFX has more cash in the bank: 79.8B vs. EKGCX (122M). RSLFX pays higher dividends than EKGCX: RSLFX (0.86) vs EKGCX (0.00). EKGCX was incepted earlier than RSLFX: EKGCX (33 years) vs RSLFX (23 years). EKGCX (2.30) is less costly to investors than RSLFX (0.70). EKGCX (32.00) and RSLFX (32.00) have comparable annual turnover. RSLFX has a lower initial minimum investment than EKGCX: RSLFX (250) vs EKGCX (1000). RSLFX annual gain was more profitable for investors over the last year : 8.91 vs. EKGCX (-5.45). RSLFX return over 5 years is better than : 19.68 vs. EKGCX (-12.78).
EKGCXRSLFXEKGCX / RSLFX
Total Expense Ratio2.220.70317%
Annual Report Gross Expense Ratio2.300.70329%
Fund Existence33 years23 years-
Gain YTD2.9689.75530%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets122M79.8B0%
Annual Yield % from dividends0.000.86-
Returns for 1 year-5.458.91-61%
Returns for 3 years-1.7627.82-6%
Returns for 5 years-12.7819.68-65%
Returns for 10 years-28.3554.16-52%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOSS1.980.14
+7.61%
Gossamer Bio
SRZN9.310.36
+4.02%
Surrozen
NEO6.460.17
+2.70%
NeoGenomics
ESTC88.86-1.00
-1.11%
Elastic NV
ENTO0.47-0.01
-1.61%
Entero Therapeutics Inc.